LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.36 | 84.90 | 5050 | 5651 | 0.8936 | 0.9632 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.06 | 84.90 | 479 | 5990 | 0.0800 | 0.3255 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.06 | 84.90 | 5635 | 5990 | 0.9406 | 0.9802 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.06 | 84.90 | 5220 | 5990 | 0.8713 | 0.9556 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.06 | 84.90 | 5291 | 5990 | 0.8832 | 0.9600 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.77 | 84.90 | 558 | 6252 | 0.0892 | 0.3547 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.77 | 84.90 | 5877 | 6252 | 0.9399 | 0.9801 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.77 | 84.90 | 5560 | 6252 | 0.8892 | 0.9625 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.77 | 84.90 | 5617 | 6252 | 0.8983 | 0.9657 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.48 | 84.90 | 527 | 6567 | 0.0802 | 0.3378 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.48 | 84.90 | 6202 | 6567 | 0.9443 | 0.9818 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.48 | 84.90 | 5794 | 6567 | 0.8822 | 0.9604 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.48 | 84.90 | 5846 | 6567 | 0.8901 | 0.9632 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 57.18 | 84.90 | 476 | 6963 | 0.0684 | 0.3115 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 57.18 | 84.90 | 6486 | 6963 | 0.9315 | 0.9778 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 57.18 | 84.90 | 6058 | 6963 | 0.8700 | 0.9567 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 57.18 | 84.90 | 6117 | 6963 | 0.8785 | 0.9597 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.88 | 84.90 | 463 | 7291 | 0.0635 | 0.3022 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.88 | 84.90 | 6796 | 7291 | 0.9320 | 0.9782 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.88 | 84.90 | 6320 | 7291 | 0.8667 | 0.9560 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.88 | 84.90 | 6367 | 7291 | 0.8732 | 0.9582 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.59 | 84.90 | 551 | 7641 | 0.0721 | 0.3339 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.59 | 84.90 | 7141 | 7641 | 0.9344 | 0.9792 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.59 | 84.90 | 6592 | 7641 | 0.8626 | 0.9550 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.59 | 84.90 | 6650 | 7641 | 0.8702 | 0.9576 | MN20160318_Q02 | N08 |